Literature DB >> 33704565

Development and validation of a nomogram to predict the risk of breast cancer-related lymphedema among Chinese breast cancer survivors.

Yan-Fei Liu1, Jun-E Liu2, Yi Zhu3, Yim Wah Mak4, Hui Qiu1, Li-Hui Liu5, Shen-Shen Yang1, Shao-Hua Chen1.   

Abstract

PURPOSE: Breast cancer-related lymphedema (BCRL) is a major long-term complication for post-surgery breast cancer survivors. Although several risk factors have been identified, lifestyle characteristics have been neglected in previous studies. The aim of this study was to develop and validate a nomogram for estimating this population's risk of developing lymphedema, taking into consideration their demographic, clinical, and personal lifestyle behaviors.
METHODS: In a cross-sectional study, we collected data from 775 post-operative breast cancer survivors who had attended a follow-up session in the recent 10 years (primary cohort). Lymphedema was assessed using the Norman telephone questionnaire, self-reported by patients. Multiple logistic regression was used to identify risk factors for lymphedema, including demographic, clinical, and lifestyle-related factors. A nomogram was constructed based on those factors and was validated using a separate group of 314 breast cancer patients (validation cohort).
RESULTS: The factors independently associated with lymphedema were higher body mass index (BMI), modified radical mastectomy (MRM), postsurgical infection, chemotherapy, radiotherapy, exercise of the affected arm, and the active participation in physical activity (P<0.05). The area under the curve (AUC) values of the primary and the validation cohorts were 0.721 (95% confidence interval: 0.685-0.756) and 0.702 (95% confidence interval: 0.646-0.759), respectively.
CONCLUSIONS: BCRL risk factors include MRM, radiotherapy, chemotherapy, and higher BMI, while the active physical activity behavior of patients appears to be a factor against lymphedema. The nomogram incorporating the patients' clinical and lifestyle factors might be useful for predicting lymphedema in breast cancer survivors.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Breast cancer; Lifestyle behaviors; Lymphedema; Nomogram; Risk factors

Year:  2021        PMID: 33704565     DOI: 10.1007/s00520-021-06122-y

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  4 in total

1.  Posttraumatic growth and associated socio-demographic and clinical factors in Chinese breast cancer survivors.

Authors:  Mu-Lan Wang; Jun-E Liu; Hui-Ying Wang; Jing Chen; Yi-Ying Li
Journal:  Eur J Oncol Nurs       Date:  2014-06-21       Impact factor: 2.398

2.  Lymphedema after Breast Cancer Treatment.

Authors:  Stanley G Rockson
Journal:  N Engl J Med       Date:  2019-02-14       Impact factor: 91.245

3.  The Early Detection of Breast Cancer Treatment-Related Lymphedema of the Arm.

Authors:  Vaughan Keeley
Journal:  Lymphat Res Biol       Date:  2020-12-02       Impact factor: 2.589

4.  A scoring system for predicting the risk of breast cancer-related lymphedema.

Authors:  Fenglian Li; Qian Lu; Sanli Jin; Quanping Zhao; Xueying Qin; Shuai Jin; Lichuan Zhang
Journal:  Int J Nurs Sci       Date:  2019-12-14
  4 in total
  1 in total

Review 1.  Prediction models for breast cancer-related lymphedema: a systematic review and critical appraisal.

Authors:  Qiu Lin; Tong Yang; Jin Yongmei; Ye Mao Die
Journal:  Syst Rev       Date:  2022-10-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.